Rankings
▼
Calendar
▼
QNTM Q4 2016 Earnings Report — Quantum BioPharma Ltd. Revenue & Financial Results | Market Cap Arena
Quantum BioPharma Ltd.
QNTM
Q4 2016 Earnings
Reported November 30, 2016
Quarter Comparison
Revenue
Operating Income
EPS (Diluted)
Free Cash Flow
Metric
Q4 2016
Q3 2016
Q4 2015
QoQ Change
YoY Change
Revenue
$0
$0
—
—
—
Op. Income
$0
$0
—
—
—
EPS (Diluted)
$-0.01
$-0.10
—
94.2%
—
Free Cash Flow
-$1.8K
-$1.4K
—
-31.2%
—
marketcaparena.com
Income Statement
Item
Amount
REVENUE
$0
Cost of Revenue
$0
GROSS PROFIT
$0
R&D Expenses
$0
Selling & Marketing
$0
General & Administrative
$565
SG&A Expenses
$565
Other Expenses
$0
Operating Expenses
$565
Cost & Expenses
$565
OPERATING INCOME
$0
Interest Income
$0
Interest Expense
$0
Other Income/Expenses
-$565
INCOME BEFORE TAX
-$565
Income Tax Expense
$0
Net Income from Continuing Ops
-$565
Net Income from Discontinued Ops
$0
Other Adjustments
$0
NET INCOME
-$565
Net Income Deductions
$0
BOTTOM LINE NET INCOME
-$565
D&A
$0
EBIT
-$565
EBITDA
-$565
EPS
-$0
EPS Diluted
-$0
marketcaparena.com
Cash Flow Statement
Item
Amount
Net Income
-$565
Depreciation & Amortization
$0
Stock-Based Compensation
$0
Deferred Income Tax
$0
Other Non-Cash Items
$0
Change in Working Capital
-$1.3K
OPERATING CASH FLOW
-$1.8K
Capital Expenditure
$0
Acquisitions (Net)
$0
Purchases of Investments
$0
Sales/Maturities of Investments
$0
Other Investing Activities
$0
NET CASH FROM INVESTING
$0
Net Debt Issuance
$0
Common Stock Repurchased
$0
Common Dividends Paid
$0
Other Financing Activities
$0
NET CASH FROM FINANCING
$0
FREE CASH FLOW
-$1.8K
Net Change in Cash
-$1.8K
marketcaparena.com
← Q3 2016
QNTM Overview
Q1 2017 →